Close

Analyst Ratings for Bristol-Myers Squibb Co. (BMY) [Neutrals]

BMY Rating Summary

BMY Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BMY
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $77.86 (+3%) * Over Last 12-Mos
Rating Score: 4.2 / 10   Percentile Rank: 39%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/3/2022 Raymond James Dane Leone Downgrade Market Perform
(Outperform)
N/A
(N/A)
75.07
(75.57)
0.67% Details
12/9/2021 Wells Fargo
» Updated 5/17/2022
Mohit Bansal New Coverage Equal Weight
(N/A)
70.00
(65.00)
57.13
(75.57)
32.28% Details
Like BMY Ratings? Also take a look at CELG, TPTX, NKTR, IMTX

BMY Ratings News